Human Gene MIR31 (ENST00000362307.1) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
CS266555 - Sequence 247 from Patent WO2005118806. DL076717 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004367 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FW421709 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW367580 - JP 2012228254-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411973 - JP 2014000079-A/247: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW674319 - JP 2014217381-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ067261 - JP 2014012020-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ427685 - JP 2014217384-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428488 - JP 2014217385-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429291 - JP 2014217386-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ430094 - JP 2014217387-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ769351 - JP 2014223080-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058745 - Sequence 247 from Patent EP2298893. JA059548 - Sequence 247 from Patent EP2298894. JA073871 - Sequence 247 from Patent EP2281887. JA105008 - Sequence 247 from Patent EP2302051. JA106348 - Sequence 247 from Patent EP2302052. JA107151 - Sequence 247 from Patent EP2302053. JA107954 - Sequence 247 from Patent EP2302054. JA108757 - Sequence 247 from Patent EP2302055. JA109560 - Sequence 247 from Patent EP2302056. JA192076 - Sequence 247 from Patent EP2290066. JA192975 - Sequence 247 from Patent EP2290067. JA193874 - Sequence 247 from Patent EP2290068. JA194773 - Sequence 247 from Patent EP2290069. JA195672 - Sequence 247 from Patent EP2290070. JA196571 - Sequence 247 from Patent EP2290071. JA197470 - Sequence 247 from Patent EP2290072. JA198369 - Sequence 247 from Patent EP2290073. JA199268 - Sequence 247 from Patent EP2290074. JA200167 - Sequence 247 from Patent EP2290075. JA201066 - Sequence 247 from Patent EP2290076. JA218188 - Sequence 247 from Patent EP2281888. JA226339 - Sequence 247 from Patent EP2292755. JA229194 - Sequence 247 from Patent EP2292756. JA257465 - Sequence 247 from Patent EP2284265. JA278745 - Sequence 247 from Patent EP2281886. JA284631 - Sequence 247 from Patent EP2281889. JA292684 - Sequence 247 from Patent EP2287303. JA317870 - Sequence 247 from Patent EP2314688. JA374929 - Sequence 247 from Patent EP2322616. JC221772 - Sequence 247 from Patent EP2471923. JC268338 - Sequence 247 from Patent EP2471924. JC340646 - Sequence 247 from Patent EP2471922. JC469892 - Sequence 247 from Patent EP2471921. JC990681 - Sequence 247 from Patent EP2808390. LF714784 - JP 2016165292-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856718 - JP 2015142597-A/247: METHODS AND COMPOSITIONS INVOLVING MicroRNA. CS266363 - Sequence 55 from Patent WO2005118806. DL076525 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004175 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FU261110 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763612 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV525893 - Nucleic acid controling mast cell degranulation. FW361129 - MIR-15, MIR -26, MIR -31, MIR -145, MIR -147, MIR -188, MIR -215, MIR -216, MIR -331, MMU-MIR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION. FW421517 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HV304511 - JP 2009531018-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305009 - JP 2009531019-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV775532 - JP 2012511031-A/2: COMPOSITIONS AND METHODS RELATING TO miR-31. HV970137 - JP 2012523000-A/24: Method for in vitro Diagnosing a Complex Disease. HW102014 - JP 2013500034-A/141: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW119218 - JP 2013046612-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW349990 - JP 2013534908-A/3: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW367388 - JP 2012228254-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411781 - JP 2014000079-A/55: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW505117 - JP 2014502606-A/19: MELANOMA TREATMENTS. HW589547 - JP 2013121348-A/78: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674127 - JP 2014217381-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW799346 - WO 2014200065-A/1: Composition for treatment or diagnosis of a colon cancer and use thereof. HZ043213 - JP 2015510401-A/303: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ043227 - JP 2015510401-A/317: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ067069 - JP 2014012020-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ081839 - JP 2015514392-A/303: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ081853 - JP 2015514392-A/317: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ408229 - JP 2015528002-A/826: CHIRAL CONTROL. HZ413351 - JP 2014060993-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427493 - JP 2014217384-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428296 - JP 2014217385-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429099 - JP 2014217386-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429902 - JP 2014217387-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ431877 - JP 2014221834-A/2: COMPOSITIONS AND METHODS RELATING TO miR-31. HZ501562 - JP 2016025853-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769159 - JP 2014223080-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058553 - Sequence 55 from Patent EP2298893. JA059356 - Sequence 55 from Patent EP2298894. JA073679 - Sequence 55 from Patent EP2281887. JA104816 - Sequence 55 from Patent EP2302051. JA106156 - Sequence 55 from Patent EP2302052. JA106959 - Sequence 55 from Patent EP2302053. JA107762 - Sequence 55 from Patent EP2302054. JA108565 - Sequence 55 from Patent EP2302055. JA109368 - Sequence 55 from Patent EP2302056. JA191884 - Sequence 55 from Patent EP2290066. JA192783 - Sequence 55 from Patent EP2290067. JA193682 - Sequence 55 from Patent EP2290068. JA194581 - Sequence 55 from Patent EP2290069. JA195480 - Sequence 55 from Patent EP2290070. JA196379 - Sequence 55 from Patent EP2290071. JA197278 - Sequence 55 from Patent EP2290072. JA198177 - Sequence 55 from Patent EP2290073. JA199076 - Sequence 55 from Patent EP2290074. JA199975 - Sequence 55 from Patent EP2290075. JA200874 - Sequence 55 from Patent EP2290076. JA217996 - Sequence 55 from Patent EP2281888. JA226147 - Sequence 55 from Patent EP2292755. JA229002 - Sequence 55 from Patent EP2292756. JA257273 - Sequence 55 from Patent EP2284265. JA278553 - Sequence 55 from Patent EP2281886. JA284439 - Sequence 55 from Patent EP2281889. JA292492 - Sequence 55 from Patent EP2287303. JA317678 - Sequence 55 from Patent EP2314688. JA374737 - Sequence 55 from Patent EP2322616. JA525928 - Sequence 78 from Patent EP2369011. JA526435 - Sequence 78 from Patent EP2369012. JA526942 - Sequence 78 from Patent EP2369013. JA535871 - Sequence 78 from Patent EP2371971. JA642944 - Sequence 2 from Patent EP2370091. JA682687 - Sequence 3 from Patent WO2011144761. JA787876 - Sequence 78 from Patent EP2479285. JA788374 - Sequence 78 from Patent EP2479286. JA810708 - Sequence 78 from Patent EP2468890. JA811206 - Sequence 78 from Patent EP2468891. JA811704 - Sequence 78 from Patent EP2468893. JA812202 - Sequence 78 from Patent EP2468894. JA812700 - Sequence 78 from Patent EP2468895. JA813198 - Sequence 78 from Patent EP2468896. JA813696 - Sequence 78 from Patent EP2468897. JA814194 - Sequence 78 from Patent EP2468898. JA814692 - Sequence 78 from Patent EP2468899. JA816935 - Sequence 78 from Patent EP2468892. JA825747 - Sequence 78 from Patent EP2471956. JA826245 - Sequence 78 from Patent EP2471958. JB024532 - Sequence 78 from Patent EP2505668. JB025030 - Sequence 78 from Patent EP2505669. JB079417 - Sequence 78 from Patent EP2487252. JB079915 - Sequence 78 from Patent EP2487253. JB080413 - Sequence 78 from Patent EP2487254. JB080911 - Sequence 78 from Patent EP2487255. JB081409 - Sequence 78 from Patent EP2487256. JB081907 - Sequence 78 from Patent EP2487257. JB082405 - Sequence 78 from Patent EP2487258. JB082903 - Sequence 78 from Patent EP2487259. JB083401 - Sequence 78 from Patent EP2487260. JB083899 - Sequence 78 from Patent EP2487261. JB084397 - Sequence 78 from Patent EP2487262. JB084895 - Sequence 78 from Patent EP2487263. JB087573 - Sequence 78 from Patent EP2502630. JB147777 - Sequence 78 from Patent EP2484782. JB148275 - Sequence 78 from Patent EP2484783. JB153000 - Sequence 78 from Patent EP2514433. JB153498 - Sequence 78 from Patent EP2514434. JB622087 - Sequence 78 from Patent EP2586454. JB622585 - Sequence 78 from Patent EP2586455. JC001648 - Sequence 78 from Patent EP2591794. JC037589 - Sequence 117 from Patent EP2643479. JC221580 - Sequence 55 from Patent EP2471923. JC268146 - Sequence 55 from Patent EP2471924. JC340454 - Sequence 55 from Patent EP2471922. JC469700 - Sequence 55 from Patent EP2471921. JC990489 - Sequence 55 from Patent EP2808390. LF404310 - JP 2015509366-A/303: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF404324 - JP 2015509366-A/317: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF706981 - JP 2016169158-A/1: Composition for treatment or diagnosis of a colon cancer and use thereof. LF714592 - JP 2016165292-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856526 - JP 2015142597-A/55: METHODS AND COMPOSITIONS INVOLVING MicroRNA. LG051563 - KR 1020150036642-A/829: CHIRAL CONTROL. LQ580781 - Sequence 2 from Patent WO2016102939. MA353841 - JP 2018075017-A/303: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA353855 - JP 2018075017-A/317: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MP045481 - Sequence 303 from Patent EP3401394. MP045495 - Sequence 317 from Patent EP3401394. MP084151 - Sequence 303 from Patent EP3401393. MP084165 - Sequence 317 from Patent EP3401393. HW350013 - JP 2013534908-A/26: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. JA682710 - Sequence 26 from Patent WO2011144761. HW350015 - JP 2013534908-A/28: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. JA682712 - Sequence 28 from Patent WO2011144761. HW350014 - JP 2013534908-A/27: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. JA682711 - Sequence 27 from Patent WO2011144761. HW350010 - JP 2013534908-A/23: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. JA682707 - Sequence 23 from Patent WO2011144761. FW364210 - Oligonucleotides for modulating target RNA activity. HI560872 - Sequence 87 from Patent EP2190992. HI965190 - Sequence 475 from Patent WO2010139812. HI965897 - Sequence 217 from Patent WO2010139811. HI966763 - Sequence 217 from Patent WO2010139810. HV593973 - JP 2010538653-A/87: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF. HV595116 - JP 2010539959-A/497: Micromirs. HW101962 - JP 2013500034-A/89: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW350011 - JP 2013534908-A/24: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW505486 - JP 2014502606-A/388: MELANOMA TREATMENTS. HW812557 - JP 2014533960-A/1: A method for predicting responsiveness to a treatment with an EGFR inhibitor. HZ073963 - JP 2013535982-A/54: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ082815 - JP 2015513906-A/172: Stem Cell Microparticles. HZ157673 - JP 2015130862-A/497: Micromirs. HZ186523 - JP 2015146814-A/272: Oligonucleotides for modulating target RNA activity. HZ436596 - JP 2015529450-A/172: Stem Cell Microparticles. HZ480105 - JP 2015535430-A/611: TERMINALLY MODIFIED RNA. HZ790036 - JP 2016504050-A/1781: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA287407 - Sequence 89 from Patent WO2011015720. JA401228 - Sequence 475 from Patent WO2011080318. JA402206 - Sequence 475 from Patent WO2011080315. JA403213 - Sequence 475 from Patent WO2011080316. JA405844 - Sequence 475 from Patent EP2336353. JA426745 - Sequence 78 from Patent WO2011072177. JA429370 - Sequence 475 from Patent WO2011095623. JA660563 - Sequence 17 from Patent WO2011131354. JA682607 - Sequence 75 from Patent WO2011149354. JA682708 - Sequence 24 from Patent WO2011144761. JA791883 - Sequence 285 from Patent WO2012089772. JA791975 - Sequence 24 from Patent WO2012089753. JB022290 - Sequence 132 from Patent WO2013026685. JB022876 - Sequence 130 from Patent WO2013026684. JB049930 - Sequence 17 from Patent WO2013020926. JB175062 - Sequence 94 from Patent WO2012101219. JB620061 - Sequence 41 from Patent WO2013063544. JB620138 - Sequence 118 from Patent WO2013063544. JB624267 - Sequence 87 from Patent EP2610342. JB779403 - Sequence 1 from Patent WO2013076282. JC037777 - Sequence 305 from Patent EP2643479. JC171800 - Sequence 172 from Patent WO2013150303. JC512768 - Sequence 3021 from Patent WO2014113089. JC572611 - Sequence 172 from Patent WO2014125276. JC582299 - Sequence 172 from Patent WO2014125277. JE953995 - Sequence 172 from Patent WO2015052526. JE955748 - Sequence 172 from Patent WO2015052527. JE978572 - Sequence 17 from Patent EP2865765. LF137500 - JP 2016507550-A/172: Method of Producing Microparticles. LF161408 - JP 2016513950-A/1474: Oligomers with improved off-target profile. LF162465 - JP 2016513095-A/172: Stem Cell Microparticles and miRNA. LF636239 - JP 2016519076-A/13: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS. LF953217 - JP 2016534103-A/172: Stem Cell Microparticles and miRNA. LG005562 - KR 1020150004822-A/172: STEM CELL MICROPARTICLES. LG053258 - KR 1020150059168-A/172: STEM CELL MICROPARTICLES. LG134396 - KR 1020150131312-A/13: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS. LG240497 - KR 1020160035087-A/172: STEM CELL MICROPARTICLES AND MIRNA. LP726523 - Sequence 217 from Patent EP2883966. LP818793 - Sequence 217 from Patent EP3296406. LP896973 - Sequence 1837 from Patent EP3253886. LP938735 - Sequence 217 from Patent EP3184651. LQ070356 - Sequence 680 from Patent EP2964234. LQ251602 - Sequence 1 from Patent EP3000895. LQ278480 - Sequence 19 from Patent WO2016066288. LQ302663 - Sequence 1 from Patent WO2016046365. LQ420483 - Sequence 59 from Patent WO2016127998. LV470582 - JP 2016534036-A/172: Stem Cell Microparticles and miRNA. LX080476 - JP 2017503478-A/1: A method for predicting responsiveness to a treatment with an EGFR inhibitor. LY336226 - KR 1020160089488-A/1: A METHOD FOR PREDICTING RESPONSIVENESS TO A TREATMENT WITH AN EGFR INHIBITOR. LY405181 - KR 1020160117535-A/486: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ233880 - JP 2017184756-A/272: Oligonucleotides for modulating target RNA activity. MA260420 - JP 2017505623-A/486: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA643857 - JP 2017113010-A/1781: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731741 - JP 2017140048-A/611: TERMINALLY MODIFIED RNA. MS673327 - Sequence 130 from Patent EP3135774. MS833382 - Sequence 87 from Patent EP3112464. MS834329 - Sequence 475 from Patent EP3112479. MS901659 - Sequence 132 from Patent EP3156505. HW350012 - JP 2013534908-A/25: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. JA682709 - Sequence 25 from Patent WO2011144761. HI979103 - Sequence 30 from Patent EP2234483. HV342485 - JP 2011510623-A/30: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY. HW350008 - JP 2013534908-A/21: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW799360 - WO 2014200065-A/15: Composition for treatment or diagnosis of a colon cancer and use thereof. JA682705 - Sequence 21 from Patent WO2011144761. LF706995 - JP 2016169158-A/15: Composition for treatment or diagnosis of a colon cancer and use thereof. HW350002 - JP 2013534908-A/15: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW799355 - WO 2014200065-A/10: Composition for treatment or diagnosis of a colon cancer and use thereof. JA682699 - Sequence 15 from Patent WO2011144761. LF706990 - JP 2016169158-A/10: Composition for treatment or diagnosis of a colon cancer and use thereof. HW799347 - WO 2014200065-A/2: Composition for treatment or diagnosis of a colon cancer and use thereof. LF706982 - JP 2016169158-A/2: Composition for treatment or diagnosis of a colon cancer and use thereof. HW350009 - JP 2013534908-A/22: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW799361 - WO 2014200065-A/16: Composition for treatment or diagnosis of a colon cancer and use thereof. JA682706 - Sequence 22 from Patent WO2011144761. LF706996 - JP 2016169158-A/16: Composition for treatment or diagnosis of a colon cancer and use thereof. HW349998 - JP 2013534908-A/11: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW799351 - WO 2014200065-A/6: Composition for treatment or diagnosis of a colon cancer and use thereof. JA682695 - Sequence 11 from Patent WO2011144761. LF706986 - JP 2016169158-A/6: Composition for treatment or diagnosis of a colon cancer and use thereof. AJ421753 - Homo sapiens microRNA miR-31. CQ873619 - Sequence 38 from Patent WO2004076622. CS166326 - Sequence 37 from Patent WO2005078096. CS265296 - Sequence 38 from Patent EP1627925. CS444351 - Sequence 38 from Patent WO2006108473. CS548396 - Sequence 1426 from Patent EP1777301. DD413456 - Regulation of Mammalian Cells. DJ003826 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ027105 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DL231868 - Method for the determination of cellular transcriptional regulation. DL233853 - Identification of novel genes encoding for small temporal RNA. FU261385 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763887 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV523082 - Identification of novel genes encoding for small temporal RNA. FV523898 - Diagnosis and therapeutic choice of head and neck tumor using micro RNA as biomarker. FV524339 - Nucleic acid controling mast cell degranulation. FW312137 - DETECTING NUCLEIC ACIDS. FW342821 - Diagnosis and therapeutic choice of head and neck tumor using micro RNA as biomarker. FW360940 - MIR-15, MIR -26, MIR -31, MIR -145, MIR -147, MIR -188, MIR -215, MIR -216, MIR -331, MMU-MIR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION. FW571148 - WO 2010119698-A/8: Head and neck tumor growth suppressant. HI979078 - Sequence 5 from Patent EP2234483. HV304786 - JP 2009531018-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305284 - JP 2009531019-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV342460 - JP 2011510623-A/5: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY. HW119493 - JP 2013046612-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW350006 - JP 2013534908-A/19: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW530038 - JP 2014094008-A/99: Identification of novel genes encoding for small temporal RNA. HW589822 - JP 2013121348-A/353: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW799358 - WO 2014200065-A/13: Composition for treatment or diagnosis of a colon cancer and use thereof. HZ413626 - JP 2014060993-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501837 - JP 2016025853-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. JA526203 - Sequence 353 from Patent EP2369011. JA526710 - Sequence 353 from Patent EP2369012. JA527217 - Sequence 353 from Patent EP2369013. JA536146 - Sequence 353 from Patent EP2371971. JA641979 - Sequence 99 from Patent EP2386637. JA663264 - Sequence 99 from Patent EP2385122. JA663481 - Sequence 99 from Patent EP2385123. JA682703 - Sequence 19 from Patent WO2011144761. JA788151 - Sequence 353 from Patent EP2479285. JA788649 - Sequence 353 from Patent EP2479286. JA810983 - Sequence 353 from Patent EP2468890. JA811481 - Sequence 353 from Patent EP2468891. JA811979 - Sequence 353 from Patent EP2468893. JA812477 - Sequence 353 from Patent EP2468894. JA812975 - Sequence 353 from Patent EP2468895. JA813473 - Sequence 353 from Patent EP2468896. JA813971 - Sequence 353 from Patent EP2468897. JA814469 - Sequence 353 from Patent EP2468898. JA814967 - Sequence 353 from Patent EP2468899. JA817210 - Sequence 353 from Patent EP2468892. JA826022 - Sequence 353 from Patent EP2471956. JA826520 - Sequence 353 from Patent EP2471958. JB024807 - Sequence 353 from Patent EP2505668. JB025305 - Sequence 353 from Patent EP2505669. JB079692 - Sequence 353 from Patent EP2487252. JB080190 - Sequence 353 from Patent EP2487253. JB080688 - Sequence 353 from Patent EP2487254. JB081186 - Sequence 353 from Patent EP2487255. JB081684 - Sequence 353 from Patent EP2487256. JB082182 - Sequence 353 from Patent EP2487257. JB082680 - Sequence 353 from Patent EP2487258. JB083178 - Sequence 353 from Patent EP2487259. JB083676 - Sequence 353 from Patent EP2487260. JB084174 - Sequence 353 from Patent EP2487261. JB084672 - Sequence 353 from Patent EP2487262. JB085170 - Sequence 353 from Patent EP2487263. JB087848 - Sequence 353 from Patent EP2502630. JB148052 - Sequence 353 from Patent EP2484782. JB148550 - Sequence 353 from Patent EP2484783. JB153275 - Sequence 353 from Patent EP2514433. JB153773 - Sequence 353 from Patent EP2514434. JB292061 - Sequence 99 from Patent EP2428569. JB302176 - Sequence 99 from Patent EP2428570. JB320131 - Sequence 99 from Patent EP2428568. JB336194 - Sequence 99 from Patent EP2428571. JB361381 - Sequence 99 from Patent EP2428567. JB622362 - Sequence 353 from Patent EP2586454. JB622860 - Sequence 353 from Patent EP2586455. JC001923 - Sequence 353 from Patent EP2591794. JC334226 - Sequence 144 from Patent EP2487240. LF706993 - JP 2016169158-A/13: Composition for treatment or diagnosis of a colon cancer and use thereof. LP637003 - Sequence 53 from Patent EP2848702. HW349997 - JP 2013534908-A/10: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW799350 - WO 2014200065-A/5: Composition for treatment or diagnosis of a colon cancer and use thereof. JA682694 - Sequence 10 from Patent WO2011144761. LF706985 - JP 2016169158-A/5: Composition for treatment or diagnosis of a colon cancer and use thereof. MS816815 - Sequence 164 from Patent WO2017085287. FZ436973 - JP 2011501966-A/20: PROCESS FOR MONITORING COLORECTAL CANCER. HW350007 - JP 2013534908-A/20: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW799359 - WO 2014200065-A/14: Composition for treatment or diagnosis of a colon cancer and use thereof. JA682704 - Sequence 20 from Patent WO2011144761. LF706994 - JP 2016169158-A/14: Composition for treatment or diagnosis of a colon cancer and use thereof. FW364209 - Oligonucleotides for modulating target RNA activity. FZ414381 - WO 2011007815-A/271: A method for screening a food which promotes production of milk having immunoregulating effect. HI560871 - Sequence 86 from Patent EP2190992. HI929401 - Sequence 8 from Patent EP2258863. HI953427 - Sequence 3 from Patent WO2010136417. HI965191 - Sequence 476 from Patent WO2010139812. HI966106 - Sequence 426 from Patent WO2010139811. HI966972 - Sequence 426 from Patent WO2010139810. HV511979 - JP 2011520454-A/94: Methods for Assessing Colorectal Cancer and Compositions for use therein. HV593972 - JP 2010538653-A/86: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF. HV595115 - JP 2010539959-A/496: Micromirs. HV775531 - JP 2012511031-A/1: COMPOSITIONS AND METHODS RELATING TO miR-31. HV821909 - JP 2011140513-A/271: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition. HV953959 - JP 2012518421-A/871: METHODS OF DETECTING LUNG CANCER. HW101910 - JP 2013500034-A/37: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW349988 - JP 2013534908-A/1: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW349999 - JP 2013534908-A/12: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW505306 - JP 2014502606-A/208: MELANOMA TREATMENTS. HW523312 - JP 2014507123-A/97: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS. HW669805 - JP 2013537538-A/536: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. HW799352 - WO 2014200065-A/7: Composition for treatment or diagnosis of a colon cancer and use thereof. HZ043104 - JP 2015510401-A/194: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ043118 - JP 2015510401-A/208: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ073962 - JP 2013535982-A/53: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ081730 - JP 2015514392-A/194: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ081744 - JP 2015514392-A/208: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ082723 - JP 2015513906-A/80: Stem Cell Microparticles. HZ157672 - JP 2015130862-A/496: Micromirs. HZ186522 - JP 2015146814-A/271: Oligonucleotides for modulating target RNA activity. HZ431876 - JP 2014221834-A/1: COMPOSITIONS AND METHODS RELATING TO miR-31. HZ436504 - JP 2015529450-A/80: Stem Cell Microparticles. HZ480137 - JP 2015535430-A/643: TERMINALLY MODIFIED RNA. HZ790068 - JP 2016504050-A/1813: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA287355 - Sequence 37 from Patent WO2011015720. JA401229 - Sequence 476 from Patent WO2011080318. JA402207 - Sequence 476 from Patent WO2011080315. JA403214 - Sequence 476 from Patent WO2011080316. JA405845 - Sequence 476 from Patent EP2336353. JA426899 - Sequence 232 from Patent WO2011072177. JA429371 - Sequence 476 from Patent WO2011095623. JA483459 - Sequence 94 from Patent EP2283161. JA642943 - Sequence 1 from Patent EP2370091. JA682543 - Sequence 11 from Patent WO2011149354. JA682685 - Sequence 1 from Patent WO2011144761. JA682696 - Sequence 12 from Patent WO2011144761. JA715089 - Sequence 871 from Patent EP2401406. JA792018 - Sequence 67 from Patent WO2012089753. JA885467 - Sequence 97 from Patent WO2012083004. JB022353 - Sequence 195 from Patent WO2013026685. JB073535 - Sequence 8 from Patent EP2546361. JB149196 - Sequence 271 from Patent EP2455486. JB175099 - Sequence 131 from Patent WO2012101219. JB615291 - Sequence 13 from Patent WO2013070079. JB616196 - Sequence 26 from Patent WO2013107459. JB620038 - Sequence 18 from Patent WO2013063544. JB620137 - Sequence 117 from Patent WO2013063544. JB624266 - Sequence 86 from Patent EP2610342. JB733787 - Sequence 3190 from Patent WO2013082448. JB835731 - Sequence 21 from Patent WO2013057567. JC023887 - Sequence 403 from Patent EP2641976. JC037521 - Sequence 49 from Patent EP2643479. JC171708 - Sequence 80 from Patent WO2013150303. JC244885 - Sequence 513 from Patent WO2012020308. JC244958 - Sequence 586 from Patent WO2012020308. JC270145 - Sequence 536 from Patent WO2012020307. JC512800 - Sequence 3053 from Patent WO2014113089. JC572519 - Sequence 80 from Patent WO2014125276. JC582207 - Sequence 80 from Patent WO2014125277. JE953903 - Sequence 80 from Patent WO2015052526. JE955656 - Sequence 80 from Patent WO2015052527. LF137408 - JP 2016507550-A/80: Method of Producing Microparticles. LF160580 - JP 2016513950-A/646: Oligomers with improved off-target profile. LF162373 - JP 2016513095-A/80: Stem Cell Microparticles and miRNA. LF404201 - JP 2015509366-A/194: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF404215 - JP 2015509366-A/208: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF636252 - JP 2016519076-A/26: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS. LF706987 - JP 2016169158-A/7: Composition for treatment or diagnosis of a colon cancer and use thereof. LF953125 - JP 2016534103-A/80: Stem Cell Microparticles and miRNA. LG005470 - KR 1020150004822-A/80: STEM CELL MICROPARTICLES. LG053166 - KR 1020150059168-A/80: STEM CELL MICROPARTICLES. LG134409 - KR 1020150131312-A/26: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS. LG240405 - KR 1020160035087-A/80: STEM CELL MICROPARTICLES AND MIRNA. LP726732 - Sequence 426 from Patent EP2883966. LP819002 - Sequence 426 from Patent EP3296406. LP896679 - Sequence 1543 from Patent EP3253886. LP938944 - Sequence 426 from Patent EP3184651. LP951914 - Sequence 420 from Patent WO2017157650. LQ070388 - Sequence 712 from Patent EP2964234. LQ251603 - Sequence 2 from Patent EP3000895. LQ302664 - Sequence 2 from Patent WO2016046365. LQ420484 - Sequence 60 from Patent WO2016127998. LV470490 - JP 2016534036-A/80: Stem Cell Microparticles and miRNA. LX270602 - JP 2016056210-A/536: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. LY405180 - KR 1020160117535-A/485: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY489857 - KR 1020170046253-A/5: Method for Evaluating Compound Toxicity Using Exosome Biomarker. LZ233879 - JP 2017184756-A/271: Oligonucleotides for modulating target RNA activity. MA260419 - JP 2017505623-A/485: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA267359 - JP 2018061445-A/93: Method for detecting urothelial cancer based on microRNA in urine using cell sorting. MA353732 - JP 2018075017-A/194: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA353746 - JP 2018075017-A/208: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA643889 - JP 2017113010-A/1813: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA730749 - JP 2017125065-A/536: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. MA731773 - JP 2017140048-A/643: TERMINALLY MODIFIED RNA. MP045372 - Sequence 194 from Patent EP3401394. MP045386 - Sequence 208 from Patent EP3401394. MP075748 - Sequence 87 from Patent WO2019002265. MP084042 - Sequence 194 from Patent EP3401393. MP084056 - Sequence 208 from Patent EP3401393. MS833381 - Sequence 86 from Patent EP3112464. MS834330 - Sequence 476 from Patent EP3112479. MS901722 - Sequence 195 from Patent EP3156505. HW349996 - JP 2013534908-A/9: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW799349 - WO 2014200065-A/4: Composition for treatment or diagnosis of a colon cancer and use thereof. JA682693 - Sequence 9 from Patent WO2011144761. LF706984 - JP 2016169158-A/4: Composition for treatment or diagnosis of a colon cancer and use thereof. HW350000 - JP 2013534908-A/13: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS. HW799353 - WO 2014200065-A/8: Composition for treatment or diagnosis of a colon cancer and use thereof. JA682697 - Sequence 13 from Patent WO2011144761. LF706988 - JP 2016169158-A/8: Composition for treatment or diagnosis of a colon cancer and use thereof. MA800910 - JP 2018183181-A/1781: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA800942 - JP 2018183181-A/1813: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129272 - Sequence 172 from Patent EP3470073. MP162195 - Sequence 172 from Patent WO2019069093. MP129180 - Sequence 80 from Patent EP3470073. MP162103 - Sequence 80 from Patent WO2019069093. MA867087 - JP 2018537983-A/106: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS. MA989791 - JP 2017529852-A/1: A method for predicting responsiveness to a treatment with an EGFR inhibitor. MB018430 - JP 2018504915-A/59: A microRNA-based method for early detection of prostate cancer in urine samples. MA867081 - JP 2018537983-A/100: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS. MA989792 - JP 2017529852-A/2: A method for predicting responsiveness to a treatment with an EGFR inhibitor. MB018431 - JP 2018504915-A/60: A microRNA-based method for early detection of prostate cancer in urine samples. MP280629 - Sequence 49 from Patent WO2019111197. MP264439 - Sequence 27 from Patent EP3502269. MP280630 - Sequence 50 from Patent WO2019111197. MP283542 - Sequence 49 from Patent WO2019111198. MP283543 - Sequence 50 from Patent WO2019111198. LY656592 - KR 1020190057529-A/1: The biomarker miRNA-31-5p for diagnosis of pre-eclampsia and use thereof. LY656594 - KR 1020190057529-A/3: The biomarker miRNA-31-5p for diagnosis of pre-eclampsia and use thereof. LY656593 - KR 1020190057529-A/2: The biomarker miRNA-31-5p for diagnosis of pre-eclampsia and use thereof. MB453663 - JP 2018509178-A/229: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids. MP545952 - Sequence 4 from Patent WO2020030561. MP328219 - Sequence 3 from Patent EP3543358. MP330020 - Sequence 3 from Patent WO2019180136. MP545951 - Sequence 3 from Patent WO2020030561.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: NR_029505, uc011lnj.1, uc011lnj.2 UCSC ID: ENST00000362307.1 RefSeq Accession: NR_029505
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|